Tylosine [INN-French],8026-48-0 Products Supply - Chemical manufacturers Network

Name: Tylosine [INN-French]
CAS NO.: 8026-48-0
Synonyms:
Fradizine;Tylocine;Tylosine;Tylosin A;Tylosin;Tilosina;Tylosinum;Tylan;Vubityl 200;Tylosine [INN-French];Tylosinum [INN-Latin];Tilosina [INN-Spanish];HSDB 7022;EINECS 215-754-8;AI3-29799;1401-69-0;Tylosin [INN:BAN];AC1O5FWL;Tylosin Tartrate (Salt);UNII-YEF4JXN031;11032-12-5 (hydrochloride);C46H77NO17;LS-158232;(10E,12E)-(3R,4S,5S,6R,8R,14S,15R)-14-((6-deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxymethyl)-5-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-l-ribo-hexopyranosyl)-3-dimethylamino-beta-d-glucopyranosyl)oxy)-6-formylmethyl-3-hydroxy-4,8,12-trimet;(10E,12E)-(3R,4S,5S,6R,8R,14S,15R)-14-((6-deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxymethyl)-5-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-dimethylamino-beta-D-glucopyranosyl)oxy)-6-formylmethyl-3-hydroxy-4,8,12-trimethyl-9-oxoheptadeca-10,12-dien-15-olide;11112-11-1;2-[(4R,6S,7R,9R,11E,13E,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde;39282-33-2;8026-48-0;Antibiotic obtained from cultures of Streptomyces fradiae, or the same substance produced by any other means
Molecular Structure:
Molecular Formula: C₄₆H₇₇NO₁₇

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: Tylosine [INN-French]; Mitomycine [INN-French]; Metilsulfate de laudexium [INN; Tylosine sulfa; Linetastine [INN]; INN 00835; Eptapirone [INN]; Merafloxacin [INN]; Mafosfamide [INN]; Antafenite [INN]; Brolaconazole [INN]; Carnitine [INN]; Pengitoxin [INN]; Azabuperone [INN]; Pirtenidine [INN]; Exbivirumab [INN]; Beminafil [INN]; Acotiamide [INN]; Bamirastine [INN]; Libivirumab [INN]; Urtoxazumab [INN]; Adecatumumab [INN]; Vapaliximab [INN]; Litomeglovir [INN]; Lemuteporfin [INN]; Atorolimumab [INN]; Vepalimomab [INN]; Ticalopride [INN]; Laniquidar [INN]; Minretumomab [INN];